Seeking Alpha

Nektar Therapeutics (NKTR)

  • Harish Mano | Send Message 2 May

    $nktr upbeat or false alarm what are we looking at?
    Reply (2)
    • BiotechX | Send Message 3 May
      : We look at excellent Q1 results - not more not less.
    • BiotechX | Send Message 1h
      : The last SA article "With Nektar Therapeutics, Value Never Comes Easy " from May, 20, describes the situation quite well.
      • Scrying Biotech | Send Message 23 Mar

        Nektar-102 Will Be An Approved Treatment In Metastatic Breast Cancer $NKTR
          • LaboMedic | Send Message 20 Mar

            $NKTR Brean Capital Maintains Buy on Nektar Therapeutics as Movantik US Salesforce Increases by 50%
              • Investors Prophet | Send Message 19 Mar

                SELL ALERTS (NASDAQ Strategy) ... $NKTR ... Prices for recent alerts:
                  • LaboMedic | Send Message 18 Mar

                    $NKTR Brean Capital Slashes Price Target for Nektar Therapeutics on Clinical Trial Setback
                      • BiotechX | Send Message 18 Mar

                        I believe market cap for $NKTR makes still sense based on recently approved MOVANTIK in USA/EU and successfulk PhIII of BAX855.
                        Reply (1)
                        • BiotechX | Send Message 18 Mar
                          : The market was not too optimistic for this difficult to treat patient group - subgroup analysis looks promissing!
                          • pat45 | Send Message 18 Mar

                            $NKTR drug failed, big market cap and needs money = short? Will watch tape but could fall big tīme.
                              • theoptionrider | Send Message 3 Mar

                                Monday & Tuesday's trades. $KO $TWTR $KN $NKTR $FNSR $AER $BBRY $SNDK
                                  • theoptionrider | Send Message 27 Feb

                                    A great Friday to wrap up a very profitable February! $WBA $SNDK $NKTR $KN $FNSR $IRM $TWTR
                                      • LaboMedic | Send Message 26 Feb

                                        $NKTR Piper Jaffray Reiterates Overweight On Nektar Therapeutics; Sees Upside From Current Levels
                                          Visit Seeking Alpha's
                                          NKTR vs. ETF Alternatives
                                          Company Description
                                          Nektar Therapeutics Inc is a clinical-stage biopharmaceutical company. The Company develops a pipeline of drug candidates that utilizes its PEGylation and polymer conjugate technology platforms that are designed to developmolecular entities.
                                          Sector: Healthcare
                                          Industry: Biotechnology
                                          Country: United States